Publications by authors named "Laura Basterretxea"

Claim this Profile
A
Avelumab maintenance in advanced urothelial carcinoma: real-world data from Northern Spain (AVEBLADDER study).
Marta Sotelo, Mireia Pelaez, Laura Basterretxea, Estrella Varga, Ricardo Sánchez-Escribano

Clin Transl Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of a 12-week multicomponent exercise programme on physical function in older adults with cancer: Study protocol for the ONKO-FRAIL randomised controlled trial.
Julia García-García, Ana Rodriguez-Larrad, Maren Martinez de Rituerto Zeberio, Jenifer Gómez Mediavilla, Borja López-San Vicente, Laura Basterretxea

J Geriatr Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot phase 2 study of the efficacy, safety, and tolerability of first-line cabozantinib for older fragile patients with metastatic renal cell carcinoma: The SOGUG-CABOMAYOR study.
Miguel A Climent, Ricardo Sanchez-Escribano, Lucía Heras, Laura Basterretxea, Jose Carlos Villa Guzmán

J Geriatr Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of miRNAs and Their Target Genes Associated with Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Patients.
María Armesto, Stéphane Nemours, María Arestín, Iraide Bernal, Jon Danel Solano-Iturri, Laura Basterretxea

Int J Mol Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferences for Renal Cell Carcinoma Pharmacological Treatment: A Discrete Choice Experiment in Patients and Oncologists.
Ovidio Fernández, Martín Lázaro-Quintela, Guillermo Crespo, Diego Soto de Prado, Álvaro Pinto, Laura Basterretxea

Front Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial.
Maria Gonzalez-Cao, Clara Mayo de Las Casas, Juana Oramas, Miguel A Berciano-Guerrero, Luis de la Cruz, Laura Basterretxea

Nat Commun· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Chemotoxicity, Unplanned Hospitalizations and Early Death in Older Patients with Colorectal Cancer Treated with Chemotherapy.
Jaime Feliu, Enrique Espinosa, Laura Basterretxea, Irene Paredero, Elisenda Llabrés

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Undertreatment and overtreatment in older patients treated with chemotherapy.
Jaime Feliu, Enrique Espinosa, Laura Basterretxea, Irene Paredero, Elisenda Llabrés

J Geriatr Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of an Early Mortality Risk Score for Older Patients Treated with Chemotherapy for Cancer.
Jaime Feliu, Alvaro Pinto, Laura Basterretxea, Borja López-San Vicente, Irene Paredero

J Clin Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Unplanned Hospitalizations in Older Patients Treated with Chemotherapy.
Jaime Feliu, Enrique Espinosa, Laura Basterretxea, Irene Paredero, Elisenda Llabrés

Cancers (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Chemotherapy Toxicity in Older Patients with Cancer: A Multicenter Prospective Study.
Jaime Feliu, Beatriz Jiménez-Munárriz, Laura Basterretxea, Irene Paredero, Elisenda Llabrés

Oncologist· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sunitinib rechallenge in advanced renal cell carcinoma: outcomes of a multicenter retrospective study.
Javier Munárriz, Gaspar Reynés, Luisa Sánchez-Lorenzo, Emilio Esteban, Laura Basterretxea

Cancer Chemother Pharmacol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective Observational Study for Assessment and Outcome Association of Circulating Endothelial Cells in Clear Cell Renal Cell Carcinoma Patients Who Show Initial Benefit from First-line Treatment. The CIRCLES (CIRCuLating Endothelial cellS) Study (SOGUG-CEC-2011-01).
Jesús García-Donas, Luis Angel Leon, Emilio Esteban, Maria Jose Vidal-Mendez, Jose Angel Arranz, Laura Basterretxea

Eur Urol Focus· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma.
Javier Puente, Nuria Laínez, Marta Dueñas, María José Méndez-Vidal, Emilio Esteban, Laura Basterretxea

Oncotarget· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study.
Nuria Lainez, Jesús García-Donas, Emilio Esteban, Javier Puente, M Isabel Sáez, Laura Basterretxea

BMC Cancer· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis